Pathological Changes Associated With Topical Chemotherapy for Superficial Bladder Cancer
- 1 October 1981
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 126 (4) , 461-464
- https://doi.org/10.1016/s0022-5347(17)54576-0
Abstract
With use of previous observations in experimental animals as a basis for comparison, the cytologic and histologic changes in human patients who underwent topical chemotherapy [mitomycin C, thiotepa] for superficial bladder cancer were documented. Despite the potential for inhibition of DNA replication these drugs apparently act in vivo as toxic substances, causing increased exfoliation with denudation of papillary and/or flat urothelium. Multinucleation was common but was confined to superficial cells. Atypical cells, such as those observed after systemic chemotherapy with cyclophosphamide, rarely were present and could be distinguished readily from neoplastic elements. Although topical chemotherapy may suppress tumor growth and progression it apparently does not eradicate the neoplastic process.This publication has 8 references indexed in Scilit:
- The morphologic effects of mitomycin c in mammalian urinary bladderCancer, 1981
- Rationale for Intensive Intravesical Chemotherapy for Superficial Bladder CancerJournal of Urology, 1980
- The effect of thio-TEPA on developing and established mammalian bladder tumorsCancer, 1980
- MORPHOLOGIC EFFECTS OF THIO-TEPA ON MAMMALIAN UROTHELIUM - CHANGES IN ABNORMAL CELLS1978
- Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancerUrology, 1977
- Mitomycin C Bladder Instillation Therapy for Bladder TumorsJournal of Urology, 1975
- The Effects of Topical Thiotepa on the Recurrence Rate of Superficial Bladder CancersJournal of Urology, 1968
- Bladder Carcinoma Treated by Direct Instillation of Thio-TepaJournal of Urology, 1962